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Abstract
Objective To determine the effectiveness of
programmes of screening in general practice for
excessive alcohol use and providing brief
interventions.
Design Systematic review and meta-analysis of
randomised controlled trials that used screening as a
precursor to brief intervention.
Setting General practice.
Main outcome measures Number needed to treat,
proportion of patients positive on screening,
proportion given brief interventions, and effect of
screening.
Results The eight studies included for meta-analysis
all used health questionnaires for screening, and the
brief interventions included feedback, information,
and advice. The studies contained several sources of
bias that might lead to overestimates of the effects of
intervention. External validity was compromised
because typically three out of four people identified
by screening as excessive users of alcohol did not
qualify for the intervention after a secondary
assessment. Overall, in 1000 screened patients, 90
screened positive and required further assessment,
after which 25 qualified for brief intervention; after
one year 2.6 (95% confidence interval 1.7 to 3.4)
reported they drank less than the maximum
recommended level.
Conclusions Although even brief advice can reduce
excessive drinking, screening in general practice does
not seem to be an effective precursor to brief
interventions targeting excessive alcohol use. This
meta-analysis raises questions about the feasibility of
screening in general practice for excessive use of
alcohol.
Introduction
General practitioners are strongly encouraged to iden-
tify and intervene with patients whose alcohol
consumption is either hazardous or harmful to their
health. Screening using standardised questioning and
brief interventions consisting of a few minutes of feed-
back, information, and advice are promoted for that
purpose.1–3 Implementation research has been carried
out,4–7 not without difficulty, and there is clearly much
still to learn about the suitability and compatibility of
brief interventions used after screening.8
Intervention can work and has been reviewed.9–14
Calculations of efficacy, which compare screening and
brief intervention versus screening and no interven-
tion or less intervention, ignore the many patients who
are lost.15 The effectiveness of screening as a precursor
to brief intervention has not been systematically
evaluated.
Because screening has become part of recommen-
dations,16 we aim to provide an estimate of the screen-
ing effect equivalent to the one introduced for disease
screening by Rembold.17 This estimate relates screen-
ing as a case finding approach to experimental events,
in our case “clinically important changes”—that is,
changes in alcohol consumption from above the
recommended levels to below these levels.18
This review aims to answer the question, how effec-
tive is screening in general practice for locating
patients who consume excessive amounts of alcohol
and can benefit from brief interventions and change
their drinking to within sensible limits?
Methods
We used the basic review and meta-analysis principles
recommended by the Cochrane collaboration and the
principles of mapping attrition set out by Feinstein.19 20
Identifying studies
AB and TT searched the electronic databases, checked
reference lists of earlier reviews and retrieved papers,
hand searched, and consulted European experts. They
then defined a final electronic search strategy (box 1)
and criteria for inclusion (box 2). Medline, Embase,
PsycInfo, Cochrane, and ETOH databases were
searched without time limits for reports in English lan-
guage on controlled trials.
Assessing validity
Internal validity—We assessed four types of bias in
each study included in the meta-analysis (selection
bias, performance bias, attrition bias, detection bias; see
table 2).19 20 The validity assessment was used only for
the discussion of differences between studies and pos-
sible bias of findings.19
External validity—We used an adaptation of
Feinstein’s model (fig 1) to assess losses from screening
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to follow up.20 This categorises the excessive drinkers
available for screening (users of the healthcare system,
those not refusing screening, not physically or psycho-
logically impaired, not illiterates, etc) into five groups.
Assessing outcomes
Absolute risk reduction (in this case an increase in
benefit) is the difference between proportions of
individuals reporting to be drinking below weekly
limits at follow up when groups were comparable at
baseline. To compute the event rates we used an inten-
tion to treat approach with the total number of
randomly assigned patients as the denominator.21
Twelve months’ follow up was the typical period, and
we used it for comparison purpose in the meta-
analysis. CIA software (Wilson method) was used for
computing confidence intervals.22
Number needed to treat equals 1 divided by the abso-
lute risk reduction. We gave confidence intervals as
suggested by Rembold,17 with negative values indicat-
ing harm and positive values indicating benefit. For
example, an NNT of +20 means that an extra patient
benefits for every 20 patients treated with the “new
intervention.”22
Screening effect—To describe the effect of screening
we estimated the number of positive events per 1000
patients screened. This figure shows the proportion of
patients who will benefit from the programme. The
screening effect is estimated as the product of the
prevalence of a treatable condition and the absolute
risk reduction from treatment.17 In our case, the preva-
lence is the number admitted for brief intervention
divided by the number screened. These prevalences
are kept fixed and not considered to deviate due to
chance in our estimations since they are primarily
determined by the screening and assessment proce-
dure of the single study rather than by any stochastic
variation.
Summarising effects across studies
We used the fixed effect Mantel-Haenszel pooling
method and the matching heterogeneity statistic for
combining results from the different studies.23 To test
the sensitivity of the pooling method we replicated the
estimations using a random effects model. The pooled
NNT value and corresponding 95% confidence
interval were obtained by inverting the pooled risk dif-
ference value and its interval. The pooled screening
effect value and its 95% confidence interval were estab-
lished by multiplying the average weighted prevalence
with the pooled absolute risk reduction and its
confidence intervals.
Results
Inclusion and description of studies
Of 309 hits on Medline, 19 papers could be included,
according for attrition mapping (table 1). PsycInfo (Sil-
verplatter) contributed one additional paper.24 One of
the 20 papers reported long term follow up of a trial
already included, and it was not included for further
assessment.25 We mapped the 19 studies according to
the different types of attrition from screening to follow
Box 1: Words and phrases used to search
databases
Subject or disorder—alcoholism, alcohol drinking,
alcohol-related disorders, substance-related disorders,
drinking behaviour, drink
Intervention—patient education, counselling,
psychotherapy, behavior therapy, patient-centered
care, patient acceptance of health care,
physician-patient relations, attitude to health,
“knowledge, attitudes, practice,” health behavior,
patient compliance, life style, prevention, advice,
intervention
Setting—family practice, primary health care,
physicians, nurse practitioners, general practice,
general practitioner, physician, nurse
Methodology—randomized controlled trial, clinical trials,
controlled clinical trials, intervention studies, outcome
and process assessment (health care), follow-up
studies, double-blind method, random allocation,
treatment outcome, randomised controlled trial,
randomised, randomized, random, comparative studies
Box 2: Criteria for including studies
• Focus on excessive alcohol use (hazardous or
harmful drinking) but not focus on a specific disease
and not focus on alcohol dependency
• Recruitment involved screening or a procedure
similar to screening
• Brief interventions were studied (minutes (not
hours) of interaction) in general practice settings (not
in hospital wards, not in emergency rooms, not in
ad hoc research clinics)
• A randomised controlled design was used to
compare outcome of a brief intervention with
outcome of no/less intervention
• Studies were included for meta-analyses if they
reported at least one discrete outcome measure
reflecting a clinically significant change in alcohol
consumption (an experimental event) and reported
the number screened to obtain the study sample
Intended population
of excessive drinkers
• Not available for screening – refuse screening, treated elsewhere, not
   using health care, etc
• Non-specified loss – no reasons for loss given or reasons poorly
   differentiated
• Not accessible at some point between screening and follow up – moved
   away, died, had no access to telephone or no address, etc
• Not eligible or excluded by protocol, typically after a thorough assessment
   – false positive screening result, superimposed conditions, comorbidity,
   comedication, non-compliance, etc
• Non-receptive group – refuse further participation at some point between
   screening and follow up
• Study participants – admitted to study and followed up according to
   protocol
Available group
Not available
Non-specified loss
Non accessible
Non-receptive
Not eligible/excluded
Study
participants
Fig 1 From intended population to admitted group
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up and estimated the numbers for each type of
attrition.
In general, a high percentage of patients who
screened positive were excluded by protocol, refused
further participation, or were not included for unspeci-
fied reasons during a secondary assessment carried out
by a researcher and taking place before the
randomisation. Typically, a few patients with severe
alcohol problems or false positive screening results
were excluded by protocol; the reasons commonly
given were low compliance, comorbidity, or were not
specified.
Inclusion in meta-analysis
Two of the 19 studies did not report the number
screened to obtain subjects for randomisation.18 26
Another nine (of which seven did not find any statisti-
cally significant differences on drinking outcome
measures) failed to fulfil the fifth criteria by not report-
ing an event outcome measure and were not included
for meta-analysis.27–35 The meta-analysis included eight
of the largest studies (table 2); one of these was a sub-
group analysis that did not contribute to the pooled
effect values.36
For screening, all eight studies used general health
or lifestyle questionnaires that included questions on
alcohol consumption. Questionnaires were provided
to patients when they came to visit their doctor. Four
studies also invited patients by mailing out
questionnaires,24 37–39 and one study telephoned
patients.37
The interventions that were provided ranged from
a 10 minute consultation24 39 to up to five consultations
lasting 5-20 minutes.40 The intervention protocols all
included feedback on present drinking, education on
risk and strategies for changing drinking, and the prac-
titioner’s advice to cut down on drinking.
Methodological quality
Table 3 shows the four key components of study
validity.19 23 One study randomised four participating
practices rather than patients37 and another one used
weekly shifts between intervention and control periods.40
All studies found sufficient blinding impossible.
In general, follow up rates were high and the US
studies all had follow up of 85% or more.36 37 41 42 The
TrEAT group studies36 41 42 did not state their sample
size considerations; their goal for consumption after
treatment was more liberal than the criteria for excess
drinking at screening, and follow up rates differed con-
siderably between allocation groups in two of these
studies (90% v 97%; P = 0.000241 and 94% v 100%;
P = 0.03936; table 3). The large UK study by Wallace et
al had a lower follow up rate for the male intervention
group (83% v 89%; P < 0.05).38
Heterogeneity
The studies varied slightly regarding inclusion criteria
and baseline prevalence. However, the outcome results
were not significantly different (test for heterogeneity
2 = 8.9, df = 6, P = 0.18). As this P value is clearly above
0.10 we accepted the fixed effect approach as sufficient
to produce an average measure of treatment effect and
reliable confidence intervals.19 43 We used a random
effects model (RevMan software44) to investigate the
robustness of the fixed effect approach.
Intervention effect and assessment efforts
The pooled absolute risk reduction was 10.5% (95%
confidence interval 7.1% to 13.9%) (table 4). A random
effects model yielded a similar result: 10% (6% to 14%).
The pooled number needed to treat (NNT) was 10
(7 to 14). NNTs of single studies ranged from 5 to 61
and all results favoured intervention to some degree
(table 4). Two studies had notably higher NNTs,24 37 and
the 95% confidence intervals of five studies include the
possibility of harm.24 36 37 41 42
All NNT values have to be interpreted in the light
of the screening and assessment activity that took place
to establish the trial sample as well as the character of
the outcome in question. Nine per cent of patients
(12 327/134 693; range in individual studies, 3.3% to
18%) screened positive; further assessment identified
2.5% (3317/143 693; range 0.9% to 5.4%) who were
given brief interventions.
Table 1 Participation and losses from positive screening to follow up in 19 general practice brief intervention studies on patients who
screened positive for excessive alcohol use (arranged by size of the available group)
First author (year)
No of
participants
No of non-receptive
patients
No of patients excluded
or not eligible
No of patients not
accessible
No of patients lost for reasons
not clearly specified
Wallace (1988)38 748 1761 1664 281 0
Fleming (1997)41 723 1096 63 190 853
Ockene (1999)37 481 41 945 293 0
Maisto (2001)35 250 1045 42 51 0
Richmond (1995)40 197 286 64 59 195
Manwell (2000)36 174 276 0 0 280
Senft (1997)27 414 20 41 84 102
Aalto (2001)29 202 362 0 0 94
Fleming (1999)42 146 272 232 6 0
Cordoba (1998)26 229 0 0 0 317
Anderson (1992)39 100 245 40 34 0
Aalto (2000)28 78 235 0 0 40
Scott (1990)24 50 195 93 14 0
Burge (1997)30 175 58 49 44 0
Seppa (1992)31 95 87 118 0 0
McIntosh (1997)32 143 106 0 16 0
Romelsjo (1989)33 72 33 151 1 1
Tomson (1998)34 72 27 120 3 0
Heather (1987)18 104 ? ? ? ?
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American and British studies defined sensible
drinking differently. The US studies included people
who drank less than in the UK studies (table 2). The
TrEAT group studies had intervention goals for sensi-
ble drinking that were more liberal than the ones they
used in their inclusion criteria,36 41 42 whereas the
studies from Britain and Australia all had goals for
sensible drinking that were more strict or equal to their
inclusion criteria limits.
Giving up binge drinking is another possible
outcome of intervention. Table 5 shows the screening
effect values for this event in the six studies that
reported this outcome.However, a strong interdepend-
ence between reduced drinking overall and lack of
binge drinking is likely, so that giving up excessive
weekly consumption also “cures” binge drinking. Only
one of the eight studies reported a combined outcome
of “safe weekly drinking and non-binge drinking.”37 In
that study giving up excessive drinking reduced binge
drinking while the number of “pure” binge drinkers
remained unchanged in both groups.
Screening effectiveness and programme outcome
The pooled screening effect was 2.6 (1.7 to 3.4) patients
per 1000 screened for achieving sensible drinking
(based on the weighted average of admission to brief
Table 2 Characteristics and results of studies of screening and brief intervention in general practice for excess alcohol consumption included for
meta-analysis
Study (country;
participants)
Screening method and
when administered
Definition of
excessive
drinking*
No screened;
screened
positive (%);
randomised (%)
Mean (SD)
drinks per
week at
baseline Intervention
Treatment
goal
(maximum
drinks*/week)
Follow up
period
Difference between groups
for main outcomes as
reported in the paper
Manwell (USA;
women aged
18-40)36
Lifestyle questionnaire
administered during
consultation
>11/week
or
≥5/occasion; 2
positive answers to
CAGE
5979; 730 (12);
205 (3.4)
14 (9) Physician advice (15
min)×2; telephone
booster×2; self help
material
13 4 years Change in No of
drinks/week: −1.7
(P=0.0039)†
ARR for binge drinking:
3.4% (P=0.0021)†
ARR for drinking above
limits: 11% (P=0.05)†
Scott (UK; women
aged 17-69)24
Health questionnaire
administered during
consultation; some patients
invited for first screening by
mail or telephone
>17/week 11521; 384
(3.3); 104§ (0.9)
30 (10) Physician advice (10
min)×1; self help
material
12 1 year Change in No of
drinks/week: −1.1 (NS)
ARR for binge drinking:
1.6% (NS)
ARR for drinking above
limits: 3.3% (NS)
Fleming (USA; men
and women aged
over 65)42
Health questionnaire
administered during
consultation
>11/week or
≥4/occasion (men),
>8/week or
≥4/occasion
(women); or
2 positive answers
to CAGE
6073; 656 (11);
158 (2.6)
16 (9) Physician advice
(10-15 min)×2;
telephone booster ×2;
self help material
20 (men),
13 (women)
1 year Change in No of
drinks/week: −5.3
(P<0.001)‡
ARR for binge drinking:
59% (P<0.005)‡
ARR for drinking above
limits: 63% (P<0.005)‡
Ockene (USA; men
and women aged
21-84)37
Health questionnaire
administered during
consultation; some patients
invited for first screening by
mail or telephone
>12/week or
≥5/occasion (men),
>9/week (women);
or ≥4/occasion or 2
positive answers to
CAGE
9772; 1760 (18);
530 (5.4)
20 (15) men;
13 (7) women
Physician or nurse
advice (5-10 min)×1;
self help material
12 (men),
9 (women)
0.5 year Change in No of
drinks/week: −2.4
(P=0.001)
ARR for binge drinking:
5.0% (P=0.32)
ARR for drinking above
limits: 20% (P=0.01)
Fleming (USA; men
and women aged
18-65)41
Health questionnaire
administered during
consultation
>14/week (men),
>11/week (women)
17695; 2925
(17); 774 (4.4)
22 (13) men;
15 (10)
women
Physician advice (15
min)×2; telephone
booster ×2; self help
material
20 (men),
13 (women)
1 year Change in No of
drinks/week: −3.5
(P<0.01)‡
ARR for binge drinking:
17% (P<0.02)‡
ARR for drinking above
limits: 30% (P<0001)‡
Richmond
(Australia; men
and women aged
18-70)40
Health questionnaire
administered during
consultation
>29/week (men),
>17/week (women)
13017; 894
(6.9); 378§ (2.9)
42 (24) men;
22 (14)
women
Physician advice (5-20
min)×1-5; self help
material
23 (men),
12 (women)
1 year Change in consumption:
−0.3 (NS)
Temporary effect on
problem score
Wallace (UK; men
and women aged
17-69)38
Health questionnaire
administered during
consultation; some patients
invited for first screening by
mail
>22/week (men),
>13/week (women)
62153; 4454
(7.2); 909 (1.5)
42 (21) men;
24 (12)
women
Physician advice (few
min)×1-5; self help
material
22 (men),
13 (women)
1 year Change in No of
drinks/week: men −6.7
(P<0.001); women −3.5
(P<0.05)
ARR for drinking above
limits: men 18% (P<0.001);
women 18% (P<0.05)
Anderson (UK; men
aged 17-69)39
Health questionnaire
administered during
consultation; some patients
invited for first screening by
mail
>29/week 8483; 524 (6.2);
259§ (3.1)
44 (11) Physician advice (10
min)×1; self help
material
18 1 year Change in No of
drinks/week −5.4 (P<0.06)
ARR for binge drinking:
30% (P<0.05)
ARR for drinking above
limits: 13% (P<0.05)
ARR=absolute risk reduction; NS=not significant; CAGE is a four questions screening test (Cut-down contemplations, Annoyed by criticism, Guilt after drinking, and use of Eye-opener to steady
nerves).
*Number of standard drinks (12 g alcohol) per week or per occasion.
†P values based on repeated measures test.
§More than two arms in study.
‡P values apply to tests for difference in means or homogeneity of proportions.
Primary care
page 4 of 7 BMJ VOLUME 327 6 SEPTEMBER 2003 bmj.com
intervention of 2.46%). In single studies, values for
screening effects varied from 0.1 to 6.2 patients per
1000 screened (table 4).
The average pooled screening effect was sensitive
to differences in the prevalence of participants
admitted to receive brief intervention. This prevalence
varied between 0.9% and 5.4% in the studies we
included. With an average risk reduction of 10.5%
(7.1% to 13.9%) the corresponding screening effect
would be 0.9 (0.6 to 1.3) patients per 1000 screened for
the prevalence of 0.9% and 5.7 (3.8 to 7.5) patients per
1000 screened for the prevalence of 5.4%.
Figure 2 shows the results of the single studies and
the pooled estimate. All results favour screening and
intervention to some degree, the results seem to be
quite homogeneous, and the pooled estimate is clearly
significant.
Discussion
If a practitioner screens 1000 patients, carries out fur-
ther assessment in 90 patients (9%) who screen
positive, and gives feedback, information, and advice to
25 (2.5%) who qualify for brief intervention, two or
three patients can be expected to have reduced their
alcohol consumption to below recommended maxi-
mum levels after 12 months.
Methodological considerations
We discovered several sources of bias, all tending
towards overestimation of effect: impossibility of blind-
ing patients and practitioners, combined with self
reported outcome measures45; three papers did not
report their sample size calculations and redefined
excessive drinking at follow up36 41 42; one paper, which
reporting better results than the others, had a shorter
follow up37; and the two largest studies may have been
affected by attrition bias.38 41 Self selection (through
mailed and telephone invitations) in some studies24 37–39
may have compromised their external validity.
We assumed that the reasons for exclusion and
dropout after a positive result on screening in the stud-
ies were similar to the reasons for the practitioner or
the patient choosing to undergo no further assessment
or intervention—these being previous attempts to give
advice, non-compliance with advice, refusal to attend
for intervention, or a false positive screening result. In
real life, screening could have a side benefit, identifying
some cases of alcohol dependency not known to the
doctor; some of these patients might be willing to be
referred for treatment. That screening itself is
Table 3 Quality of studies included in meta-analysis
First author Sample size
Validity assessment criteria
Randomisation
(selection bias)
Blinding
(performance bias)
Follow up
(attrition bias)
Sample size calculations
(detection bias)
Manwell36 205 ++ − + (97%; I<C) −
Scott24 104 ++ + (research staff) + (69%; I=C) ++
Fleming42 158 + − ++ (92%; I=C) −
Ockene37 530 − (4 practices) + (research staff) ++ (91%; I=C) +
Fleming41 774 ++ − + (93%; I<C) −
Richmond40 378 − (weekly shifts) + (research staff) + (69%; I=C) ++
Wallace38 909 + + (research staff) − (82%; I<C) ++
Anderson39 192 ++ + (research staff) + (65%; I=C) ++
Selection bias: Randomisation quality and description of randomisation (− not justified, + fully described or valid procedure, ++ described and valid procedure)
Performance bias: Blinding and description of blinding; includes between groups detection bias (− no blinding, + single blinded, ++ double blinded)
Attrition bias: Follow up rate and differences between intervention group (I) and controls (C): (− <85% and different rates, + ≥85% or no difference, ++ ≥85% and
no difference)
Detection bias (regarding multiple outcome measures): Sample size calculated and justified (− not justified, + partially justified, ++ fully justified)
Table 4 Outcomes in studies included in meta-analysis. Values in parentheses are 95% confidence intervals
Study
Intervention group
(EER)*
Control group
(CER)*
Absolute risk
reduction (%)
(EER−CER)
Number needed to
treat (1÷ARR)
Proportion (%) of
screened patients
given intervention† Screening effect‡
Manwell36 83/103 71/102 11.0 (−0.9 to 22.5) 9 (4 to −113) 3.43 3.8 (−0.3 to 7.7)
Scott24 9/33 10/39 1.6 (−18.1 to 21.9) 61 (5 to −6) 0.90 0.1 (−1.6 to 1.9)
Fleming42 66/87 44/71 13.9 (−0.5 to 27.9) 7 (4 to −195) 2.60 3.6 (−0.1 to 7.3)
Ockene§37 102/274 66/256 11.4 (3.5 to 19.1) 9 (5 to 28) 5.42 6.2 (1.9 to 10.3)
Fleming41 277/392 247/382 6.0 (−0.6 to 12.5) 17 (8 to −171) 4.37 2.6 (−0.3 to 5.5)
Richmond40 16/96¶ 13/93¶ 2.7 (−7.8 to 13.1) 37 (8 to −13) 2.90 0.8 (−2.3 to 3.8)
Wallace38 116/448 48/459 15.4 (10.5 to 20.4) 6 (5 to 10) 1.46 2.2 (1.5 to 3.0)
Anderson39 14/80 4/74 12.1 (1.8 to 22.4) 8 (4 to 54) 3.05 3.7 (0.5 to 6.8)
Subtotal (pooled
estimate)
600/1410 432/1374 10.5 (7.1 to 13.9) 10 (7 to 14) 2.46 2.6 (1.7 to 3.4)
Test for heterogeneity: 2=8.9, df=6, P=0.18; test for overall effect: z=6.03, df=1, P<0.0001.
*Proportions of sensible drinkers at follow up.
†Number randomised÷number screened.
‡Screening effect=ARR×(% given intervention)/1000.
§This trial had 6 months’ follow up.
¶Calculated from percentages given in text (not found in tables of article).
Table 5 Screening effect (per 1000 screened) for non-binge drinking (occasional
excessive drinking) in studies that included this outcome measure
First author
Maximum No of drinks
per occasion
Number needed to treat
(95% CI)
Screening effect
(95% CI)
Manwell36 4 (women) 7 (4 to 29) 5.3 (1.2 to 9.2)
Scott24 11 (women) 7 (−13 to 3) 1.3 (−0.7 to 3.2)
Fleming42 4 (men); 3 (women) 7 (−75 to 3) 0.7 (−0.3 to 7.5)
Ockene30 5 (men); 3 (women) 21 (−31 to 8) 2.6 (−1.7 to 7.0)
Fleming41 5 (men); 3 (women) 10 (6 to 26) 4.6 (1.7 to 7.4)
Anderson39 5 (men) 4 (3 to 10) 7.5 (2.9 to 11.6)
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beneficial is an assumption that remains untried, and
counterproductive effects from alienation and badly
timed screening have to be considered.
Pooled numbers needed to treat derived from
meta-analyses can be misleading.46 For NNTs to be
comparable, they must define patients’ condition and
its severity and the intervention, its outcome, and the
setting, which they did in the present analysis.
Nevertheless cultural, age, and sex differences should
be taken into consideration, and single studies might
contribute valuable information that should not be
eclipsed by pooled estimates. Although the study by
Anderson and the TrEAT trial both attempted to
exclude people who were highly dependent on
alcohol, the nature of the “events”might differ between
men who drink heavily (included if > 29 drinks; mean
consumption 44 drinks, goal 18; screening effect 3.7
per 1000)39 and less heavy drinkers (included if > 14
drinks; mean 22, goal 20; screening effect 2.6 per
1000).41 Positive net benefit is still possible when the
screening effect is 2.6 per 1000 screened. The TrEAT
study group has published an economic analysis show-
ing a benefit-cost ratio of 5.6 (0.4 to 11.0).47 Aside from
methodological problems and the crudeness of such a
measure, one crucial problem remains. Screening for
excessive drinking is in keen competition with other
proposals for screening and prevention. A recent
paper points out that a doctor in primary care needs
7.4 hours per working day to provide the preventive
services recommended by US Preventive Services Task
Force.48 Family doctors would have to give up other
activities to free resources for a programme that would
result in safer drinking habits for only a handful of
their patients.
Drinking and general practice
The literature on brief intervention documents that a
patient who is drinking excessively may reduce their
alcohol consumption once a practitioner speaks to
them. But if change occurs in only two or three of 90
patients who screened positive and were assessed
further, the practitioner who screened 1000 patients to
find those 90 could perceive this as a 97% disappoint-
ment rate.
Conversations about drinking may take place in
many ways in general practice. Sensitively raising the
subject, or facilitating patients’ initiatives, may be a key
characteristic of good clinical practice. Future research
might focus on how a well established helping
relationship can cover drinking related problems and
risks in a way that benefits the patient and appeals to
the practitioner.
The Medical Research Council suggests a stepwise
framework for developing and evaluating randomised
controlled trials for complex interventions to improve
health.49 This approach includes modelling and
exploratory research phases defining constant and
variable elements of interventions, as well as evaluating
the effectiveness of programmes in actual practice.
In the meantime, we propose a focus on the fact
that information and advice is sometimes helpful,
especially when rapport has been established and the
agenda agreed on. Assessment of drinking, not only in
groups with obvious alcohol related problems but also
in groups of patients with symptoms correlated with
high consumption (hypertension, dyspepsia, depres-
sion, injuries, social problems, etc), lies within the doc-
tor’s role. To help patients change their lifestyle,
practitioners need and want supplementary training.
These processes of improving good clinical practice
could also be considered complex interventions, and
trials could be developed accordingly.
Conclusions
Although even brief advice can make a difference, this
review calls into question the model of universal
screening in general practice as a case finding
approach. Alcohol screening, assessment, and inter-
vention are laborious and time consuming activities
that only two or three people out of 1000 screened will
benefit from. A practitioner who experiences such a
low ratio of success to workload is bound to be
disappointed and reluctant to engage any further even
though the screening approach is consistent and utili-
tarian by nature and may seem beneficial from a popu-
lation perspective.
Future research should focus on other ways than
systematic screening of addressing excessive drinking
What is already known on this topic
Even a few minutes of feedback, information, and
advice by a general practitioner can make some
excessive drinkers change to alcohol consumption
within sensible consumption limits
General practitioners are strongly encouraged to
screen their patients and intervene with those
whose alcohol consumption is either hazardous or
harmful to their health
What this study adds
The internal and external validity of trials of
screening based brief interventions is questionable
Only one in four patients who screen positive for
excessive drinking qualify for brief intervention
after further assessment
Only two to three patients per thousand screened
will benefit from the laborious activities entailed in
screening
Manwell 2000
Scott 1990
Fleming 1999
Ockene 1999
Fleming 1997
Richmond 1995
Wallace 1988
Anderson 1992
Total
7 6 5 4 3 2 1 0 -1 -2 -3 -4 -5 -6 -7
Benefit Harm
Screening effect per 1000 screened
Fig 2 Effect of screening for excessive drinking: number of patients
with a positive outcome (reduction in drinking to below maximum
recommended limits) per 1000 screened
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among patients in general practice. More attention
should be paid to the preconditions of and skills for
successful interviewing, exchange of information,
advice giving, and counselling.
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